Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 4:16:e21.
doi: 10.15420/usc.2021.32. eCollection 2022.

Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement

Affiliations
Review

Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement

Arthur J Lee et al. US Cardiol. .

Abstract

The treatment of aortic stenosis has evolved in recent years with the introduction of transcatheter aortic valve replacement (TAVR) as a complementary strategy to surgical aortic valve replacement (SAVR). The majority of clinical trials to date have included only tricuspid aortic stenosis and excluded bicuspid aortic valves (BAVs). BAVs are associated with unique challenges related to their anatomy, clinical presentation, and association with aortopathy. BAV has a spectrum of phenotypes and the classification is still evolving. There have been no definitive clinical guidelines on triaging BAV patients towards TAVR or SAVR. Given that TAVR is moving from high-risk to low-risk patients and becoming more widely used in the treatment of BAV, there are many factors that must be considered. The aim of this article is to review the literature and present considerations for heart teams to discuss in order to offer patients the best lifetime management strategy for BAV stenosis.

Keywords: Aortic stenosis; aortopathy; bicuspid; surgical aortic valve replacement; transcatheter aortic valve replacement.

PubMed Disclaimer

Conflict of interest statement

Disclosure: KBH is a speaker and proctor for Edwards Lifesciences and is on trial steering committees for Abbott. MS is a speaker and proctor for Edwards Lifesciences, is on an advisory board and is a proctor for Abbott, and is on a steering committee for Medtronic. All other authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Bicuspid Valve Classification Using the Sievers Classification
Figure 2:
Figure 2:. Bicuspid Aortic Valve Classification

References

    1. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133:1226–33. doi: 10.1016/j.jtcvs.2007.01.039. - DOI - PubMed
    1. Michelena HI, Della Corte A, Evangelista A et al. International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. J Thorac Cardiovasc Surg. 2021;162:e383–414. doi: 10.1016/j.jtcvs.2021.06.019. - DOI - PubMed
    1. Rodríguez-Palomares JF, Dux-Santoy L, Guala A et al. Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease. J Cardiovasc Magn Reson. 2018;20:28. doi: 10.1186/s12968-018-0451-1. - DOI - PMC - PubMed
    1. Giusti B, Sticchi E, De Cario R et al. Genetic bases of bicuspid aortic valve: the contribution of traditional and high-throughput sequencing approaches on research and diagnosis. Front Physiol. 2017;8:612. doi: 10.3389/fphys.2017.00612. - DOI - PMC - PubMed
    1. Puskas JD, Gerdisch M, Nichols D et al. Anticoagulation and antiplatelet strategies after On-X mechanical aortic valve replacement. J Am Coll Cardiol. 2018;71:2717–26. doi: 10.1016/j.jacc.2018.03.535. - DOI - PubMed

LinkOut - more resources